Loading...

BEAT HEARTBEAM INC US FDA Inspections 8-K Filing

HRTB

BT

HEARTBEAM INC

(BEAT)

2025 8-K

FDA Response Received

Changes in management or co...

Management Changes

Management Change

Sales Agreement with Public...

Appointments and Retirement

Regain of Compliance with N...

Agreement for Stock Purchase

Secondary Offering

Regulation FD Disclosure

Agreement to Sell Common St...

Departure of Directors

Agreement with Investor

Sales Agreement with A.G.P....

Appointment of President

External Links:

On November 20, 2025, HeartBeam, Inc. reported receiving a Not Substantially Equivalent letter from the FDA regarding its ECG Synthesis Software application, and it plans to work towards a resolution. The company is also considering launching its 3D ECG system, which was cleared by the FDA in December 2024.

AI Assistant

HEARTBEAM INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.